- Software
- Diagnostics
- Products
- Services
Femtech market size was valued at USD 28,563.2 million in 2023 and is projected to reach a value of USD 38,870.6 million by 2030, at a CAGR of 4.5% from 2024-2030. The market refers to technology solutions that address women's health issues and needs, such as fertility, mental health, pelvic and sexual health, pregnancy, childcare, menstruation, menopause, contraception, and other general health concerns. It includes a diverse variety of products and services, such as software, medical devices, wearables, and diagnostic tools, with the goal of filling gaps in women's healthcare by providing more targeted, personalized, and accessible solutions via technology.
The FemTech industry has recently seen considerable interest and investment, notably in fields such as fertility, maternal health, and sexual wellness. For instance, Progyny, a fertility benefits management firm, went public in 2019 with a valuation of more than $1 billion, and by 2022, its market capitalization had increased to $4 billion. Another example is Cayaba Care, a digital platform that offers cheap at-home care for pregnant moms, which raised $12 million in Series A funding in 2022. Despite this spike in interest, overall investment for FemTech remains lower than in other healthcare sectors, making it difficult for startups to build traction and scale their businesses. Implementing digital solutions in healthcare demands significant resources, which might impede business advancement.
However, McKinsey's research indicates that public awareness of FemTech is increasing as more startups enter the market and upgrade services. This opens new chances to make FemTech goods more accessible to women around the world. Venture capitalists (VCs) must better understand the industry's pain issues to make informed investment decisions, while customers want accurate information about these new services. Helaina, a firm that offers milk alternatives and nursing support, is one example of this dynamic. It got prominence during the 2022 infant formula shortage in the US. Initially, however, several VCs did not see the product's value, highlighting the continued problem for FemTech startups in gaining investor support.
Femtech Market Key Developments
- In December 2023, Guidea, an award-winning UX design agency run by women, announced the selection of 30 early stage femtech startups for its Femovate sponsorship program in 2024. These companies were chosen from 130 applicants from six continents. Guidea launched the Femovate program in 2022, and it has invested more than $1 million in femtech innovation through its UX design sponsorship program. It also elevates promising femtech businesses by providing them with the same services that Guidea delivers to the top Fortune 100 firms.
- In November 2023, Bayer and CrossBay Medical announced a collaboration to create a novel intrauterine system inserter. The new inserter will be designed to reduce the agony that women endure during IUS insertion.
Femtech Market Summary
Study Period
2024-2030Base Year
2023CAGR
4.5%Largest Market
Asia-PacificFastest Growing Market
North-AmericaFemtech Market Dynamics
The Covid-19 epidemic has been a primary driving force in which increase in interest in FemTech during the pandemic, as digital health devices became vital not just for managing Covid-19 but also for fulfilling other healthcare demands. Another significant factor is the tendency toward healthcare consumerization, particularly among Millennials and Generation-Z, who have higher digital expectations and desire to integrate digital solutions into every aspect of their lives. Technological developments, notably the rapid development of AI, are accelerating growth. Furthermore, broader cultural trends have highlighted unmet women's health needs and the significance of gender-specific care. Movements to de-stigmatize themes such as menstruation, menopause, and sexual health, as well as raising awareness of gender disparities in non-reproductive disorders, have increased demand for FemTech developments.
Despite being considered as a booming new sector with the potential to enhance women's health outcomes, the FemTech business continues to confront considerable obstacles, particularly regarding funding. Historically, the women's health tech sector has been underfunded and neglected by investors, with FemTech businesses frequently viewed as niche investments. The industry is likewise very new and has received little research. Only 4% of healthcare research and development money is dedicated to women's health issues, and a lack of representation in clinical trials impedes understanding of female physiology, health conditions, therapeutic efficacy, and adverse effects. As a result, FemTech companies struggle to obtain complete data on women's health, limiting their capacity to build successful solutions. This lack of attention has resulted to 84% of women feeling ignored in healthcare settings, with their pain routinely discounted and their ailments misdiagnosed.
North-America Got Significant Share In
Femtech Market Regional Analysis
Based on regions, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. North America's excellent technology infrastructure is critical to promoting wider use of digital health solutions such as mobile apps, wearable devices, and telemedicine platforms. This solid technological foundation allows for the seamless integration of FemTech innovations, which serve to address a variety of women's health requirements through accessible and efficient digital solutions.
The region's solid investment landscape contributes to the expansion of the FemTech sector. Venture capital firms are increasingly recognizing FemTech's potential for fostering innovation and product development with significant financial backing. This infusion of funds allows startups and established businesses to experiment with new technologies and expand their offerings in areas such as fertility, prenatal care, and sexual health. Technological improvements, such as the incorporation of artificial intelligence (AI) into FemTech devices, are also projected to propel market expansion throughout the projection period. For example, in February 2023, a women's health firm in Texas developed an AI-powered chat application modeled by ChatGPT, demonstrating how cutting-edge technology can be used to improve women's healthcare experiences. These improvements are helping to expand adoption of FemTech applications, resulting in significant market growth in North America.
In addition to its superior technological infrastructure and strong investment landscape, the United States stays at the forefront the global FemTech market, accounting for more than half of all FemTech enterprises. This leadership position is fueled by the country's rich innovative ecosystem, advantageous investment climate, and rising demand for digital health solutions. The most recent 2021 Global FemTech Industry study from FemTech Analytics, a subsidiary of Deep Knowledge Group, highlights this dominance, with Europe accounting for 25% and Asia accounting for 8% of FemTech enterprises worldwide. These regional dynamics demonstrate the global expansion of the FemTech industry, with North America remaining the market leader while Europe and Asia exhibit potential growth as key regions contributing to the market's total development.
Latin America
Europe
Asia Pacific
Middle East
North America
Femtech Market Segmentation
By Type
By Product Type
- Diagnostics
- Monitoring
- Therapeutic
- Consumer Products
By Application
- Maternity Care
- Menstrual Health
- Pelvic and Uterine
- Cancer and Chronic Disease
- General Health & Wellness
- Others
By End User
- Hospitals
- Fertility Clinics
- Surgical Centres
- Diagnostic Centres
- Others
Frequently Asked Questions
The global femtech market size was valued at USD 28,563.2 million in 2023 and is projected to grow at a CAGR of 4.5% from 2024-2030.
The femtech market key palyers are Biowink GmbH, Sustain Natural, Minerva Surgical
Digital health, wearable devices, artificial intelligence, and telemedicine innovations have fueled FemTech growth, making healthcare more individualized and accessible to women.
Millennials and Generation-Z, who are more technologically savvy, are increasingly adopting digital healthcare solutions, adding to the demand for FemTech breakthroughs.
Key Features of the Report
- The femtech market report provides granular level information about the Market size, regional Market share, historic Market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key Market developments, and key strategies.
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the Market.
- The report tracks recent innovations, key developments, and start-up details that are actively working in the Market.
- The report provides a plethora of information about Market entry strategies, regulatory framework, and reimbursement scenarios.
| 1.Executive Summary |
| 2.Global Femtech Market Introduction |
| 2.1.Global Femtech Market - Taxonomy |
| 2.2.Global Femtech Market - Definitions |
| 2.2.1.Type |
| 2.2.2.Product Type |
| 2.2.3.Application |
| 2.2.4.End-user |
| 2.2.5.Region |
| 3.Global Femtech Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Femtech Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Femtech Market By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Software |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Diagnostics |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Products |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Services |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6.Global Femtech Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Diagnostics |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Monitoring |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Therapeutic |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Consumer Products |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global Femtech Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Maternity Care |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Menstrual Health |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Pelvic and Uterine |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Cancer and Chronic Disease |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. General Health & Wellness |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Others |
| 7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.6.3. Market Opportunity Analysis |
| 8.Global Femtech Market By End-user, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Hospitals |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Fertility Clinics |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Surgical Centres |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Diagnostic Centres |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Others |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.Global Femtech Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.North America Femtech Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Software |
| 10.1.2.Diagnostics |
| 10.1.3.Products |
| 10.1.4.Services |
| 10.2. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Diagnostics |
| 10.2.2.Monitoring |
| 10.2.3.Therapeutic |
| 10.2.4.Consumer Products |
| 10.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Maternity Care |
| 10.3.2.Menstrual Health |
| 10.3.3.Pelvic and Uterine |
| 10.3.4.Cancer and Chronic Disease |
| 10.3.5.General Health & Wellness |
| 10.3.6.Others |
| 10.4. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Hospitals |
| 10.4.2.Fertility Clinics |
| 10.4.3.Surgical Centres |
| 10.4.4.Diagnostic Centres |
| 10.4.5.Others |
| 10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Femtech Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Software |
| 11.1.2.Diagnostics |
| 11.1.3.Products |
| 11.1.4.Services |
| 11.2. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Diagnostics |
| 11.2.2.Monitoring |
| 11.2.3.Therapeutic |
| 11.2.4.Consumer Products |
| 11.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Maternity Care |
| 11.3.2.Menstrual Health |
| 11.3.3.Pelvic and Uterine |
| 11.3.4.Cancer and Chronic Disease |
| 11.3.5.General Health & Wellness |
| 11.3.6.Others |
| 11.4. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Hospitals |
| 11.4.2.Fertility Clinics |
| 11.4.3.Surgical Centres |
| 11.4.4.Diagnostic Centres |
| 11.4.5.Others |
| 11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 12.Asia Pacific (APAC) Femtech Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Software |
| 12.1.2.Diagnostics |
| 12.1.3.Products |
| 12.1.4.Services |
| 12.2. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Diagnostics |
| 12.2.2.Monitoring |
| 12.2.3.Therapeutic |
| 12.2.4.Consumer Products |
| 12.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Maternity Care |
| 12.3.2.Menstrual Health |
| 12.3.3.Pelvic and Uterine |
| 12.3.4.Cancer and Chronic Disease |
| 12.3.5.General Health & Wellness |
| 12.3.6.Others |
| 12.4. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Hospitals |
| 12.4.2.Fertility Clinics |
| 12.4.3.Surgical Centres |
| 12.4.4.Diagnostic Centres |
| 12.4.5.Others |
| 12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Femtech Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Software |
| 13.1.2.Diagnostics |
| 13.1.3.Products |
| 13.1.4.Services |
| 13.2. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Diagnostics |
| 13.2.2.Monitoring |
| 13.2.3.Therapeutic |
| 13.2.4.Consumer Products |
| 13.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Maternity Care |
| 13.3.2.Menstrual Health |
| 13.3.3.Pelvic and Uterine |
| 13.3.4.Cancer and Chronic Disease |
| 13.3.5.General Health & Wellness |
| 13.3.6.Others |
| 13.4. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Hospitals |
| 13.4.2.Fertility Clinics |
| 13.4.3.Surgical Centres |
| 13.4.4.Diagnostic Centres |
| 13.4.5.Others |
| 13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Femtech Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 14.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Software |
| 14.1.2.Diagnostics |
| 14.1.3.Products |
| 14.1.4.Services |
| 14.2. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Diagnostics |
| 14.2.2.Monitoring |
| 14.2.3.Therapeutic |
| 14.2.4.Consumer Products |
| 14.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Maternity Care |
| 14.3.2.Menstrual Health |
| 14.3.3.Pelvic and Uterine |
| 14.3.4.Cancer and Chronic Disease |
| 14.3.5.General Health & Wellness |
| 14.3.6.Others |
| 14.4. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Hospitals |
| 14.4.2.Fertility Clinics |
| 14.4.3.Surgical Centres |
| 14.4.4.Diagnostic Centres |
| 14.4.5.Others |
| 14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Athena Feminine Technologies |
| 15.2.2.HeraMED |
| 15.2.3.iSono Health |
| 15.2.4.Sera Prognostics |
| 15.2.5.Biowink GmbH |
| 15.2.6.Elvie |
| 15.2.7.Nuvo Cares |
| 15.2.8.Minerva Surgical |
| 15.2.9.Prelude |
| 15.2.10.Sustain Natural |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- Athena Feminine Technologies
- HeraMED
- iSono Health
- Sera Prognostics
- Biowink GmbH
- Elvie
- Nuvo Cares
- Minerva Surgical
- Prelude
- Sustain Natural